What we're reading, December 15, 2015: call centers overwhelmed by last-minute rush for health insurance enrollment; AstraZeneca exploring deal with Acerta Pharma; and despite near universal health insurance coverage in Massachusetts, patients have access issues.
Affordable Care Act call centers were overwhelmed by the large numbers of consumers trying to enroll in healthcare coverage that would be effective January 1, 2016, before the deadline at midnight on Tuesday, according to USA Today. There were so many calls that some people were asked to leave their names and contact information. If they called back after the deadline, they would still be able to have their coverage start on January 1, according to CMS.
AstraZeneca is looking to get in on the deal frenzy happening in healthcare. The United Kingdom drugmaker is considering a deal with Acerta Pharma, which would give AstraZeneca acalabrutinib, reported Bloomberg Business. The experimental drug is a rival of Imbruvica, and shows promise against an incurable form of leukemia, as well as auto-immune diseases. The 2 companies are still in talks, but the deal could cost more than $5 billion, according to The Wall Street Journal.
Finally, a study has found that while Massachusetts has near universal health insurance coverage, access to care remains a struggle, according to MassLive.com. More than one-fifth of residents have trouble getting a timely appointment. More than one-third of respondents said they had visited the emergency department in the last year, and of those, 38% said it was for something that could have been treated by a non-emergency doctor. Close to 60% said they went to the emergency department because they couldn’t get an appointment with a doctor in a timely manner.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More